Log in or Sign up for Free to view tailored content for your specialty!
Bone Marrow Transplantation News
Eight important updates in blood cancer treatment
September is designated as National Blood Cancer Awareness Month.
Pretransplantation mogamulizumab increases risk for GVHD–related mortality
Receipt of mogamulizumab prior to allogeneic hematopoietic stem cell transplantation significantly increased risk for graft-versus-host disease–related mortality in adults with T-cell leukemia/lymphoma, according to a retrospective analysis of a large database study.
Log in or Sign up for Free to view tailored content for your specialty!
Cord-blood transplantation may be preferable for patients with minimal residual disease
Patients with pretransplantation minimal residual disease achieved comparable outcomes after receipt of a hematopoietic cell transplantation from an umbilical cord blood source or HLA–matched unrelated donor, according to retrospective study results.
Blue ribbon panel presents research road map for cancer moonshot initiative
The national cancer moonshot initiative’s blue ribbon panel delivered 10 recommendations to form a 5-year research blueprint to accelerate progress against cancer at the NCI’s National Cancer Advisory Board meeting.
Bendamustine-based salvage regimen induces responses in relapsed, refractory Hodgkin lymphoma
Salvage therapy with bendamustine, gemcitabine and vinorelbine induced complete response prior to autologous hematopoietic stem cell transplantation in a large proportion of patients with relapsed or refractory Hodgkin lymphoma, according to multicenter, open-label phase 2 study results.
ASTRO Annual Meeting to reflect theme of ‘enhancing value, improving outcomes’
The American Society for Radiation Oncology will hold its annual meeting from Sept. 25 to 28 in Boston.
Cancer survivors report similar sexual activity, function as others their age
Sexual activity and function appeared no different in cancer survivors than in cancer-free adults aged 50 years or older, according to results of a population-based study.
In the Journals Plus now live on Healio.com/HemOnc
Healio.com/HemOnc has launched In the Journals Plus, a new feature that will provide busy physicians with summaries of the top articles from leading journals in hematology and oncology.
Mesenchymal stromal cell infusions reduce chronic GVHD risk after haploidentical HSCT
Repeated infusions of mesenchymal stromal cells reduced the incidence of chronic graft-versus-host disease in patients who underwent haploidentical hematopoietic stem cell transplantation, according to results of a double blind randomized controlled phase 2 study.
Cytomegalovirus does not protect against hematologic relapse after HSCT
Cytomegalovirus infection conferred no protective effect against hematologic relapse in patients with leukemia who underwent hematopoietic stem cell transplantation, according to the results of an international registry study.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read